Found 91 results
Author Keyword Title Type [ Year(Desc)]
Filters: Author is Stevens, Jan F  [Clear All Filters]
2022
Khorani M, Bobe G, Matthews DG, Magana AAlcazar, Caruso M, Gray NE, Quinn JF, Stevens JF, Soumyanath A, Maier CS.  2022.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.. J Alzheimers Dis. 85(4):1601-1619.
Bouranis JA, Beaver LM, Jiang D, Choi J, Wong CP, Davis EW, Williams DE, Sharpton TJ, Stevens JF, Ho E.  2022.  Interplay between Cruciferous Vegetables and the Gut Microbiome: A Multi-Omic Approach.. Nutrients. 15(1)
Keller RM, Beaver LM, Prater MC, Truong L, Tanguay RL, Stevens JF, Hord NG.  2022.  Nitrate exposure reprograms hepatic amino acid and nutrient sensing pathways prior to exercise: A metabolomic and transcriptomic investigation in zebrafish .. Front Mol Biosci. 9:903130.
Wright KM, Bollen M, David J, Speers AB, Brandes MS, Gray NE, Magana AAlcazar, McClure C, Stevens JF, Maier CS et al..  2022.  Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial.. Antioxidants (Basel). 11(2)
Miranda CL, Kumbi Y, Wu W, Lee H-S, Reed RL, Stevens JF.  2022.  Phytochemical characterization and bioactivity toward breast cancer cells of unhydrolyzed and acid-hydrolyzed extracts of .. Nat Prod Commun. 17(7)
Cabey K, Long DM, Law A, Gray NE, McClure C, Caruso M, Lak P, Wright KM, Stevens JF, Maier CS et al..  2022.   Withania somnifera and Centella asiatica Extracts Ameliorate Behavioral Deficits in an In Vivo Drosophila melanogaster Model of Oxidative Stress.. Antioxidants (Basel). 11(1)
Kundu P, Paraiso IL, Choi J, Miranda CL, Kioussi C, Maier CS, Bobe G, Stevens JF, Raber J.  2022.  Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet.. Dis Model Mech. 15(11)
Langley BO, Ryan JJoan, Phipps J, Buttolph L, Bray B, Aslan JE, Metz TO, Stevens JF, Bradley R.  2022.  Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.. Trials. 23(1):885.

Pages